Please try another search
CLSA Premium Limited, an investment holding company, sells healthcare products and other services in Australia, Hong Kong, and New Zealand. The company operates through Healthcare Products and Margin Dealing segments. It also offers leveraged foreign exchange trading, commodity and index trading, leveraged bullion, and other trading services. In addition, the company provides management, and cash dealing services. It serves independent traders, fund managers, professional asset management institutions, financial institutions, foreign trade businesses, and banks. The company was formerly known as KVB Kunlun Financial Group Limited and changed its name to CLSA Premium Limited in November 2019. CLSA Premium Limited was incorporated in 2010 and is headquartered in Hong Kong, Hong Kong. CLSA Premium Limited is a subsidiary of CITIC Securities International Company Limited.
Name | Age | Since | Title |
---|---|---|---|
Zhaoxia Hu | 71 | 2019 | Independent Non-Executive Director |
Jianqiang Xu | 42 | 2018 | Non-Executive Director |
Jiong Li | 54 | 2018 | Non-Executive Chairman |
Jianfeng Wu | 47 | 2019 | Independent Non-Executive Director |
Feng Yuan | 39 | 2019 | Deputy CEO & Executive Director |
Cheuk Fan Chung | 44 | 2021 | Executive Director and Head of Legal & Compliance |
Anyang Ma | 62 | 2024 | Independent Non Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review